Myc, along with other stem cell genes like SOX2, BMI1 and OCT-4, is highly expressed in prostate cancer cells having the CD44+/CD24– phenotype, which is considered a hallmark of stem/progenitor cells (36, 98). This evidence concerns the gene MYC and Familial prostate cancer.